Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum β-lactamase-producing Enterobacteriaceae

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 3, 2008, Pages

  Lu, Chin Te ^a   Chuang, Yin Ching ^b   Sun, Wu ^c   Liu, Yung Ching ^d   Cheng, Yu Jen ^e   Lu, Po Liang ^f   Chen, Chih Ming ^g   Hsu, Gwo Jong ^h   Jang, Tsrang Neng ⁱ   Lee, Chun Ming ^j   Chiang, Ping Cherng ^k   Shi, Zhi Yuan ^l   Wang, Lih Shinn ^m   Kung, Hsiang Chi ⁿ   Lin, Hsiu Chen ^o   Liao, Chun Hsing ^p   Liu, Jien Wei ^q   Huang, Cheng Hua ^r   Tsao, Shih Ming ^s   Hsueh, Po Ren ⁿ  

^a LOTUNG POH AI HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Pao Chien Hospital   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^h CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

ⁱ SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^j MACKAY MEMORIAL HOSPITAL   (Taiwan)

^k CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^l TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^m BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

ⁿ NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^o TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^p FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^q CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^r CATHAY GENERAL HOSPITAL   (Taiwan)

^s CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

Broth microdilution; Enterobacteriaceae; Etest; Extended spectrum beta lactamase; Taiwan; Tigecycline

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; TIGECYCLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TAIWAN;

EID: 55649108849     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70024-4     Document Type: Article

References (24)

1. Finland M. Twenty-fifth anniversary of the discovery of Aureomycin: the place of the tetracyclines in antimicrobial therapy. Clin Pharmacol Ther 15 (1974) 3-8
2. Speer B.S., Shoemaker N.B., and Salyers A.A. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev 5 (1992) 387-399
3. Kasbekar N. Tigecycline: a new glycylcycline antimicrobial agent. Am J Health Syst Pharm 63 (2006) 1235-1243
4. Stein G.E., and Craig W.A. Tigecycline: a critical analysis. Clin Infect Dis 43 (2006) 518-524
5. Lauderdale T.L., McDonald L.C., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., et al. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis 48 (2004) 211-219
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: M100-S16; 16th informational supplement (2006), Clinical and Laboratory Standard Institute, Wayne, PA
7. nd ed. (2001), National Committee for Clinical and Laboratory Standards, Wayne, PA
8. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 8 (2002) 132-137
9. Liu Y.C., Huang W.K., Huang T.S., and Kunin C.M. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine. Lancet 354 (1999) 1360
10. Chang C.F., Chang L.C., Chang Y.F., Chen M., and Chiang T.S. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine. J Vet Diagn Invest 14 (2002) 153-157
11. Jean S.S., Teng L.J., Hsueh P.R., Ho S.W., and Luh K.T. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram- negative bacteria in a Taiwanese University Hospital. J Antimicrob Chemother 49 (2002) 69-76
12. Hsueh P.R., Chen W.H., and Luh K.T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26 (2005) 463-472
13. Huang Y.T., Liao C.H., Teng L.J., and Hsueh P.R. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Clin Microbiol Infect 14 (2008) 124-129
14. Scheetz M.H., Qi C., Warren J.R., Postelnick M.J., Zembower J., Obias A., et al. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51 (2007) 1621-1626
15. Fritsche T.R., Strabala P.A., Sader H.S., Dowzicky M.J., and Jones R.N. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates. Diagn Microbiol Infect Dis 52 (2005) 209-213
16. Hoban D.J., Bouchillon S.K., and Dowzicky M.J. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Diagn Microbiol Infect Dis 57 (2007) 423-428
17. Gales A.C., Sader H.S., and Fritsche T.R. Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers. Diagn Microbiol Infect Dis 60 (2008) 421-427
18. DiPersio J.R., and Dowzicky M.J. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents 29 (2007) 518-527
19. Biedenbach D.J., Beach M.L., and Jones R.N. In vitro antimicrobial activity of GAR- 936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis 40 (2001) 173-177
20. Sader H.S., Jones R.N., Dowzicky M.J., and Fritsche T.R. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 52 (2005) 203-208
21. Sader H.S., Jones R.N., Stilwell M.G., Dowzicky M.J., and Fritsche T.R. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Diagn Microbiol Infect Dis 52 (2005) 181-186
22. Tiengrim S., Tribuddharat C., and Thamlikitkul V. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. J Med Assoc Thai 89 Suppl 5 (2006) S102-S105
23. Bradford P.A., Petersen P.J., Young M., Jones C.H., Tischler M., and O'Connell J. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother 49 (2005) 3903-3909
24. Petersen P.J., and Bradford P.A. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates. Antimicrob Agents Chemother 49 (2005) 3910-3918